D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

“We recognize that those with rare diseases often have complex needs that go unmet by traditional assistance,” said Green.

Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Having a child with vs. without cystic fibrosis heightened the odds for job lock and curtailed employment among parents/caregivers, according to a research letter published in JAMA Pediatrics.“U.S.

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

"Net sales increased during the fourth quarter by 41.5 percent to SEK 64.2 million, compared with the corresponding quarter of 2023. The growth and strong performance are a result of robust developmen ...

The "Respiratory Care Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market size for Respiratory Care Devices is estimated at US$24.4 ...